Shire Ltd. is pursuing a lawsuit against Apotex Inc., Apotex Corp. and Apotex Pharmaceutical Holdings Inc. for the alleged infringement of U.S. Patent Nos. 5,912,013 and 5,326,570.
The patents-at-issue cover an…
Shire Ltd. is pursuing a lawsuit against Actavis South Atlantic LLC and Actavis Inc. for the alleged infringement of U.S. Patent Nos. 5,912,013 and 5,326,570 in the U.S. District Court…
Shire Ltd.’s suit against Colony Pharmaceuticals Inc. and Actavis Inc. in the U.S. District Court for the District of Maryland for the alleged infringement of U.S. Patent Nos. 6,322,819, 6,605,300,…
A two day trial is scheduled for the week of Dec. 8, 2008, in Generics UK Ltd.’s rectification action against Shire Ltd.
Generics UK seeks a declaration that the duration of…
Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged infringement of ADDERALL XR patents was settled on March 6, 2008.
In February 2005, the Company was notified that Teva…
The U.S. District Court for the District of Colorado has not yet ruled on the summary judgment motions filed in Shire Ltd.’s suit against Sandoz Inc. for the alleged infringement…
Magistrate Judge Shipp will hold a pre-trial conference on Sept. 15, 2008, in Shire Ltd.’s suit against CorePharma LLC for the alleged infringement of U.S. Patent Nos. 5,912,013.
The patent-at-issue covers…
Shire Human Genetics Technologies Inc. continues to face Amgen Inc.’s remanded patent infringement suit in the U.S. District Court for the District of Massachusetts.
Shire Human Genetics is a subsidiary of…
Shire Ltd. is pursuing two suits against Nostrum Pharmaceuticals Inc. in the U.S. District Court for the District of New Jersey for the alleged infringement of U.S. Patent Nos. 5,912,013…
Angiotech Pharmaceuticals Inc. announced on July 10, 2008, that the highest court of the United Kingdom, the House of Lords, confirmed the validity of one of the Company’s patents related…